跳至主要内容
临床试验/EUCTR2010-019581-82-DE
EUCTR2010-019581-82-DE进行中(未招募)不适用

The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients with Type 2 Diabetes Mellitus - GBD

Eli Lilly & Company0 个研究点目标入组 693 人开始时间: 2010年5月21日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
693

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Men and nonpregnant women aged =18 years with type 2 diabetes, treated with 1 or more oral antidiabetic medicines, an HbA1c =7.0% and =9.5%, a BP >90/60 mmHg and <140/90 mmHg; if hypertensive on 3 or less antihypertensive medications (same regimen for at least 1 month), and a stable weight with a BMI =23 kg/m2, will be enrolled.
  • See protocol for full details of inclusion criteria.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • See protocol for full details of exclusion criteria.

研究者

发起方
Eli Lilly & Company

相似试验